Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trialJordana B. Cohen, Julio A. Chirinos, Nelson R. Rosado‐Santander et al.|The Lancet Respiratory Medicine|2021Cited by 224
Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial ProtocolJordana B. Cohen, Julio A. Chirinos, Thomas C. Hanff et al.|Journal of Clinical Hypertension|2020Cited by 19